Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 2
1990 5
1991 4
1992 2
1993 1
1994 3
1995 8
1996 7
1997 16
1998 4
1999 8
2000 5
2001 11
2002 6
2003 9
2004 6
2005 10
2006 10
2007 9
2008 15
2009 17
2010 15
2011 18
2012 18
2013 20
2014 15
2015 13
2016 18
2017 16
2018 16
2019 17
2020 20
2021 10
2022 7
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

330 results

Results by year

Filters applied: . Clear all
Page 1
HIV-1 remission and possible cure in a woman after haplo-cord blood transplant.
Hsu J, Van Besien K, Glesby MJ, Pahwa S, Coletti A, Warshaw MG, Petz L, Moore TB, Chen YH, Pallikkuth S, Dhummakupt A, Cortado R, Golner A, Bone F, Baldo M, Riches M, Mellors JW, Tobin NH, Browning R, Persaud D, Bryson Y; International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT) P1107 Team. Hsu J, et al. Among authors: van besien k. Cell. 2023 Mar 16;186(6):1115-1126.e8. doi: 10.1016/j.cell.2023.02.030. Cell. 2023. PMID: 36931242 Free PMC article.
Low-grade lymphoma.
Winter JN, Gascoyne RD, Van Besien K. Winter JN, et al. Among authors: van besien k. Hematology Am Soc Hematol Educ Program. 2004:203-20. doi: 10.1182/asheducation-2004.1.203. Hematology Am Soc Hematol Educ Program. 2004. PMID: 15561684 Review.
Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL.
Ruan J, Moskowitz A, Mehta-Shah N, Sokol L, Chen Z, Kotlov N, Nos G, Sorokina M, Maksimov V, Sboner A, Sigouros M, van Besien K, Horwitz S, Rutherford SC, Mulvey E, Revuelta MV, Xiang J, Alonso A, Melnick A, Elemento O, Inghirami G, Leonard JP, Cerchietti L, Martin P. Ruan J, et al. Among authors: van besien k. Blood. 2023 May 4;141(18):2194-2205. doi: 10.1182/blood.2022018254. Blood. 2023. PMID: 36796016 Clinical Trial.
Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL.
Awasthi R, Pacaud L, Waldron E, Tam CS, Jäger U, Borchmann P, Jaglowski S, Foley SR, van Besien K, Wagner-Johnston ND, Kersten MJ, Schuster SJ, Salles G, Maziarz RT, Anak Ö, Del Corral C, Chu J, Gershgorin I, Pruteanu-Malinici I, Chakraborty A, Mueller KT, Waller EK. Awasthi R, et al. Among authors: van besien k. Blood Adv. 2020 Feb 11;4(3):560-572. doi: 10.1182/bloodadvances.2019000525. Blood Adv. 2020. PMID: 32045475 Free PMC article. Clinical Trial.
Hematological manifestations of COVID-19.
Mina A, van Besien K, Platanias LC. Mina A, et al. Among authors: van besien k. Leuk Lymphoma. 2020 Dec;61(12):2790-2798. doi: 10.1080/10428194.2020.1788017. Epub 2020 Jul 9. Leuk Lymphoma. 2020. PMID: 32643489 Review.
Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia.
Sugita M, Yamazaki T, Alhomoud M, Martinet J, Latouche JB, Golden E, Boyer O, Van Besien K, Formenti SC, Galluzzi L, Guzman ML. Sugita M, et al. Among authors: van besien k. Cell Death Dis. 2023 May 4;14(5):305. doi: 10.1038/s41419-023-05829-6. Cell Death Dis. 2023. PMID: 37142568 Free PMC article.
Reply to Caldwell et al.
Satlin MJ, Chen L, Douglass C, Hovan M, Davidson E, Soave R, La Spina M, Gomez-Arteaga A, van Besien K, Mayer S, Phillips A, Hsu JM, Malherbe R, Small CB, Jenkins SG, Westblade LF, Kreiswirth BN, Walsh TJ. Satlin MJ, et al. Among authors: van besien k. Clin Infect Dis. 2022 Aug 24;75(1):180-181. doi: 10.1093/cid/ciab1001. Clin Infect Dis. 2022. PMID: 34864913 Free PMC article. No abstract available.
Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients.
Mahmood SS, Riedell PA, Feldman S, George G, Sansoterra SA, Althaus T, Rehman M, Mead E, Liu JE, Devereux RB, Weinsaft JW, Kim J, Balkan L, Barbar T, Lee Chuy K, Harchandani B, Perales MA, Geyer MB, Park JH, Palomba ML, Shouval R, Tomas AA, Shah GL, Yang EH, Gaut DL, Rothberg MV, Horn EM, Leonard JP, Van Besien K, Frigault MJ, Chen Z, Mehrotra B, Neilan TG, Steingart RM. Mahmood SS, et al. Among authors: van besien k. Eur Heart J. 2023 Jun 9;44(22):2029-2042. doi: 10.1093/eurheartj/ehad117. Eur Heart J. 2023. PMID: 36939851 Free PMC article.
Donor graft genotypes versus leukemia.
Choe HK, van Besien K. Choe HK, et al. Among authors: van besien k. Leuk Lymphoma. 2019 Jul;60(7):1606-1607. doi: 10.1080/10428194.2019.1613542. Leuk Lymphoma. 2019. PMID: 31238818 No abstract available.
330 results